FARMALOGG AS

0369 OSLO

Finances

Share Ownership

Return on Equity

92,92 %

Current Ratio

1,75

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	15 902 000	15 373 000	14 277 000	12 691 000
Net Income	3 949 000	3 744 000	2 662 000	1 655 000
Total Assets	9 837 000	9 463 000	7 565 000	6 232 000
Total Equity	4 250 000	2 740 000	2 740 000	2 660 000

Income (NOK)	2022	2021	2020	2019
Revenue	15 902 000	15 373 000	14 277 000	12 691 000
Expenditure	10 975 000	10 595 000	10 946 000	10 635 000
Operating Profit	4 927 000	4 779 000	3 330 000	2 056 000
Financial Income	136 000	15 000	21 000	84 000
Financial Costs	1 000	0	1 000	2 000
Financial Balance	135 000	15 000	20 000	82 000
Earnings Before Tax	5 063 000	4 793 000	3 350 000	2 138 000
Tax	1 114 000	1 049 000	688 000	483 000
Net Income	3 949 000	3 744 000	2 662 000	1 655 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	40 000	3 000	146 000	523 000
Total Current Assets	9 797 000	9 461 000	7 419 000	5 709 000
Total Assets	9 837 000	9 463 000	7 565 000	6 232 000
Total Retained Equity	3 750 000	2 240 000	2 240 000	2 160 000
Total Equity	4 250 000	2 740 000	2 740 000	2 660 000
Total Long-Term Debt	0	0	13 000	46 000
Total Current Debt	5 587 000	6 723 000	4 812 000	3 526 000
Total Equity and Debt	9 837 000	9 463 000	7 565 000	6 232 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	15 902 000	15 373 000	14 277 000	12 691 000
Other Income	0	0	0	0
Revenue	15 902 000	15 373 000	14 277 000	12 691 000
Cost of Goods Sold	0	0	0	0
Salary Costs	5 541 000	5 239 000	4 690 000	4 888 000
Depreciation	13 000	145 000	377 000	507 000
Impairment	0	0	0	0
Expenditure	10 975 000	10 595 000	10 946 000	10 635 000
Operating Profit	4 927 000	4 779 000	3 330 000	2 056 000
Financial Income	136 000	15 000	21 000	84 000
Financial Costs	1 000	0	1 000	2 000
Financial Balance	135 000	15 000	20 000	82 000
Dividends	2 439 000	3 744 000	2 582 000	1 454 000
Net Income	3 949 000	3 744 000	2 662 000	1 655 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	1 000	1 000	139 000	489 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	38 000	1 000	7 000	34 000
Total Tangible Assets	38 000	1 000	7 000	34 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	40 000	3 000	146 000	523 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	9 333 000	8 426 000	5 913 000	4 883 000
Total Current Assets	9 797 000	9 461 000	7 419 000	5 709 000
Total Assets	9 837 000	9 463 000	7 565 000	6 232 000
Total Equity	4 250 000	2 740 000	2 740 000	2 660 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	13 000	46 000
Creditors	1 091 000	902 000	456 000	577 000
Unpaid Taxes	460 000	560 000	612 000	348 000
Dividends	2 439 000	3 744 000	2 582 000	1 454 000
Other Current Debt	483 000	454 000	441 000	696 000
Total Current Debt	5 587 000	6 723 000	4 812 000	3 526 000
Total Equity and Debt	9 837 000	9 463 000	7 565 000	6 232 000

Financial indicators	2022	2021	2020	2019
Return on Equity	92,92 %	136,64 %	97,15 %	62,22 %
Debt-to-Equity Ratio	0	0	0	0,02
Operating Profit Margin	30,98 %	31,09 %	23,32 %	16,2 %
Current Ratio	1,75	1,41	1,54	1,62
Quick Ratio	1,75	1,41	1,54	1,62
Equity Ratio	0,43	0,29	0,36	0,43
Gross Profit Margin	100 %	100 %	100 %	100 %